To detect signaling pathways that may be involved in pancreatic cancer cell death through TLR2 and TLR9 intrabody-mediated intracellular inhibition, we performed a Western blot analysis of STAT3 phosphorylation changes in the treated cells. The gene discussed is TLR2; the disease is familial pancreatic carcinoma.